Envestnet Asset Management
ABMD

Envestnet Asset Management’s Abiomed Inc ABMD Stock Holding History

Envestnet Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-107,425
Closed -$26.4M – 4115
2022
Q3 		$26.4M Buy
107,425
+1,564
+1% +$422K 0.02% 649
2022
Q2 		$26.2M Buy
105,861
+4,106
+4% +$1.11M 0.01% 661
2022
Q1 		$33.7M Buy
101,755
+56,410
+124% +$17.4M 0.02% 628
2021
Q4 		$16.3M Buy
45,345
+7,194
+19% +$2.43M 0.01% 935
2021
Q3 		$12.4M Buy
38,151
+6,268
+20% +$2.12M 0.01% 1020
2021
Q2 		$9.95M Buy
31,883
+4,578
+17% +$1.4M 0.01% 1137
2021
Q1 		$8.7M Buy
27,305
+4,487
+20% +$1.44M 0.01% 1122
2020
Q4 		$7.4M Buy
22,818
+5,857
+35% +$1.62M 0.01% 1077
2020
Q3 		$4.7M Buy
16,961
+8,095
+91% +$2.33M ﹤0.01% 1206
2020
Q2 		$2.14M Buy
8,866
+2,875
+48% +$577K ﹤0.01% 1533
2020
Q1 		$870K Buy
5,991
+896
+18% +$149K ﹤0.01% 1896
2019
Q4 		$869K Sell
5,095
-7,321
-59% -$1.36M ﹤0.01% 2115
2019
Q3 		$2.21M Buy
12,416
+2,213
+22% +$478K ﹤0.01% 1495
2019
Q2 		$2.66M Sell
10,203
-160
-2% -$42.5K ﹤0.01% 1383
2019
Q1 		$2.96M Sell
10,363
-6,278
-38% -$2.09M ﹤0.01% 1275
2018
Q4 		$5.41M Buy
16,641
+16,051
+2,721% +$5.58M 0.01% 848
2018
Q3 		$265K Sell
590
-1,375
-70% -$542K ﹤0.01% 1075
2018
Q2 		$803K Sell
1,965
-20
-1% -$7.25K ﹤0.01% 1135
2018
Q1 		$606K Sell
1,985
-271
-12% -$68.7K ﹤0.01% 1133
2017
Q4 		$422K Sell
2,256
-119
-5% -$22.2K ﹤0.01% 1560
2017
Q3 		$398K Buy
2,375
+28
+1% +$4.23K ﹤0.01% 1569
2017
Q2 		$335K Sell
2,347
-874
-27% -$117K ﹤0.01% 1679
2017
Q1 		$404K Buy
3,221
+558
+21% +$64.7K ﹤0.01% 1632
2016
Q4 		$302K Buy
2,663
+60
+2% +$6.95K ﹤0.01% 1717
2016
Q3 		$335K Sell
2,603
-2,543
-49% -$305K ﹤0.01% 1777
2016
Q2 		$562K Sell
5,146
-395
-7% -$39.3K ﹤0.01% 1594
2016
Q1 		$525K Sell
5,541
-222
-4% -$18.7K ﹤0.01% 1614
2015
Q4 		$520K Buy
5,763
+356
+7% +$30.2K ﹤0.01% 1571
2015
Q3 		$502K Sell
5,407
-447
-8% -$39.4K ﹤0.01% 1598
2015
Q2 		$385K Sell
5,854
-439
-7% -$29.2K ﹤0.01% 1841
2015
Q1 		$450K Buy
+6,293
New +$342K ﹤0.01% 1600

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Envestnet Asset Management's ABMD Position: Q4 2022 in Review

Envestnet Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 107,425 shares — an estimated $26.4M sold.

Envestnet Asset Management first reported a position in ABMD in Q1 2015 and held it in 31 quarters. The position peaked at $33.7M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Envestnet Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 107,425 Abiomed Inc shares in Q4 2022, an estimated $26.4M.
  • Envestnet Asset Management first reported a position in Abiomed Inc in Q1 2015 and held it in 31 quarters.
  • Envestnet Asset Management's Abiomed Inc position peaked at $33.7M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Envestnet Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.